Ignite Creation Date:
2025-12-24 @ 6:51 PM
Ignite Modification Date:
2026-02-26 @ 6:52 AM
Study NCT ID:
NCT04189757
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-11-21
First Post:
2019-12-03
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Acalabrutinib for the Treatment of Ibrutinib-Intolerant Mantle Cell Lymphoma
Sponsor:
Organization: